Short description
GeneDx uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.
Description
GeneDx is focused on delivering personalized, actionable insights that improve health outcomes. GeneDx sit at the intersection of diagnostics and data science, pairing decades of genomic expertise with an unmatched ability to interpret clinical data at scale.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Stamford, Connecticut, United States, North America
Founded on
January 1, 2017
Exited on
July 23, 2021
Went public on
July 23, 2021
Stock symbol
WGS
Non-profit?
No
Acquired?
No
Employees count
1001-5000
Revenue range
$34056 - 789030
Sign in for full access
Investors
Noaccessforu, Cannot Access, Noaccess, Noway Youcantaccess, Blurry Noaccess, Noway Youcantaccess, Noaccessforu, Noaccess, Noaccess, Blurry Noaccess, Absolutely Noaccess, Uh Ohhhh, Noaccess, Cannot Access, Noway Youcantaccess, Cannot Access, Cannot Access
Sign in for full access
Founders
Eric Schadt